NO972613L - Anvendelse av additiver i kontrastmidler for å forbedre avbildning - Google Patents

Anvendelse av additiver i kontrastmidler for å forbedre avbildning

Info

Publication number
NO972613L
NO972613L NO972613A NO972613A NO972613L NO 972613 L NO972613 L NO 972613L NO 972613 A NO972613 A NO 972613A NO 972613 A NO972613 A NO 972613A NO 972613 L NO972613 L NO 972613L
Authority
NO
Norway
Prior art keywords
additives
contrast agents
improve imaging
imaging
improve
Prior art date
Application number
NO972613A
Other languages
English (en)
Other versions
NO972613D0 (no
Inventor
Werner Krause
Ulrich Speck
Wolf-Ruediger Press
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO972613L publication Critical patent/NO972613L/no
Publication of NO972613D0 publication Critical patent/NO972613D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46—Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/62—Unsaturated compounds containing ether groups, groups, groups, or groups containing rings other than six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Anvendelse av prostasyklinderi- vater, samt anvendelse av urea for for- bedring av avbildningen ved røntgen-, ultralyd-, nukleær- eller MRI-diagno- stikk.
NO972613A 1994-12-09 1997-06-06 Anvendelse av additiver i kontrastmidler for å forbedre avbildning NO972613D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944446694 DE4446694A1 (de) 1994-12-09 1994-12-09 Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung
PCT/EP1995/004826 WO1996017629A1 (de) 1994-12-09 1995-12-08 Verwendung von zusätzen zu kontrastmitteln zur verbesserung der bildgebung

Publications (2)

Publication Number Publication Date
NO972613L true NO972613L (no) 1997-06-06
NO972613D0 NO972613D0 (no) 1997-06-06

Family

ID=6537194

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972613A NO972613D0 (no) 1994-12-09 1997-06-06 Anvendelse av additiver i kontrastmidler for å forbedre avbildning

Country Status (6)

Country Link
EP (1) EP0789594A1 (no)
JP (1) JPH10509691A (no)
CA (1) CA2207025A1 (no)
DE (1) DE4446694A1 (no)
NO (1) NO972613D0 (no)
WO (1) WO1996017629A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2150497A (en) * 1996-01-25 1997-08-20 Schering Aktiengesellschaft Improved concentrated injection and infusion solutions for intravenous adminis tration
WO2000076496A1 (fr) * 1999-06-14 2000-12-21 Toray Industries, Inc. Composes facilitant l'accumulation de medicaments dans des tissus tumoraux
US7803149B2 (en) 2002-07-12 2010-09-28 Cook Incorporated Coated medical device
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450149A (en) * 1981-06-15 1984-05-22 Research Corporation Radiohalogenation method
JPH0669966B2 (ja) * 1989-07-05 1994-09-07 株式会社ミドリ十字 血管造影補助剤
US5334369A (en) * 1991-06-11 1994-08-02 Medical University Of South Carolina Platelet receptor antagonists useful in detecting intravascular platelet aggregation
DE4135193C1 (no) * 1991-10-22 1993-03-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De

Also Published As

Publication number Publication date
JPH10509691A (ja) 1998-09-22
WO1996017629A1 (de) 1996-06-13
CA2207025A1 (en) 1996-06-13
DE4446694A1 (de) 1996-06-13
NO972613D0 (no) 1997-06-06
EP0789594A1 (de) 1997-08-20

Similar Documents

Publication Publication Date Title
NO923821L (no) Diagnostiske midler
DK89794A (da) Diagnostisk middel til anvendelse ved in vivo NMR-diagnostik, fremgangsmåde til fremstilling heraf samt komplekse salte velegnede til anvendelse i det diagnostiske middel
HUT67298A (en) Complexing agents, targeting radioactive immunoreagents having utility in therapeutic and diagnostic imaging compositions
DK528385D0 (da) Kontrastmidler
DE69428146D1 (de) Ultraschallwellen medizinisches Behandlungsgerät, verwendbar im Gebrauch bei der Führung durch Magnet-Resonanz-Bilddarstellung
HK1030018A1 (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
BG101024A (en) Monoclonal antibody active against cd44v6
FR2472141B1 (fr) Poele destine notamment au camping, au caravaning et au nautisme
ATE187340T1 (de) Kontrastmittel
NO972613L (no) Anvendelse av additiver i kontrastmidler for å forbedre avbildning
SE9402880D0 (sv) New peptide derivatives
ATE140219T1 (de) Chelatbildende mittel
TR199903144T2 (xx) Entraven�z kontrast maddelerinin projeksiyon mamografisi i�in kullan�l���
ATE315423T1 (de) Radiotherapeutische vorrichtung zur behandlung der prostata
ES2059779T3 (es) Compuestos anti-androgenos.
ATE134988T1 (de) Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen
ATE106752T1 (de) Sichtbarmachung von tumoren mit technetiummarkierten kohlenhydraten.
NO972046L (no) Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike
LAM The administration of cost accounting standards[Ph. D. Thesis]
GR3023486T3 (en) Use of hydroxynaphthalenes in colouring agents
Gawande Evaluation process for the examination of curved surface workpieces using coordinate measuring instruments
Laicher Nuclear Magnetic Resonance Studies of Water Self-in Lung.
IT1244704B (it) Gruppo di sonde gemoniche utile nella diagnosi della leucemia acuta promielocitica e quale componente di un corredo diagnostico
IT1305965B1 (it) Metodo per la generazione d'immagini tomografiche in risonanzamagnetica nucleare.
Missal Reduction of Infrasonic Emissions of a Foundry